Attending the conference were Deputy Minister of Health Bakytbek Kadyraliev, representatives of the Jogorku Kenesh, the World Health Organization, as well as heads of medical institutions, international partners, and experts in the field of medicine.
During the discussions, participants summarized the work of the pediatric oncology service, which has developed since Kyrgyzstan joined the WHO Global Initiative to Combat Childhood Cancer. Approximately 200–220 new cases of cancer in children are registered annually in the republic, which is associated with improved diagnostics and the implementation of clinical protocols, as well as the development of a national cancer registry.
Specialized departments for pediatric oncology and oncohematology operate in Bishkek and Osh. In 2024, the country plans to conduct the first autologous bone marrow transplant for a child, which will be an important step in the development of high-tech care. Work continues on expanding the transplantation program, creating a modern laboratory base, and implementing new therapy methods, as stated in the report.
The head of the pediatric oncology department at the National Center for Oncology and Hematology, Sultan Stambekov, noted that the service has reached a new level of quality in recent years.
"Kyrgyzstan's participation in the WHO Global Initiative on Childhood Cancer allows for the implementation of international treatment standards and the development of a system based on evidence-based medicine. We aim to gradually increase the survival rates of children to the standards of developed countries and ensure access to modern diagnostic and therapeutic methods, including bone marrow transplantation and cellular technologies," he emphasized.
In his speech, Bakytbek Kadyraliev highlighted the importance of introducing innovative treatment methods, such as preparation for CAR-T therapy.
"The development of pediatric oncology is not only a matter of image but also a matter of saved lives. The state must create a sustainable system that ensures treatment for children without dependence on charitable fundraising. We aim to reduce the need for treatment abroad, expand high-tech care in the country, and strengthen international cooperation," he noted.
The conference also focused on issues of early diagnosis, staff training, and increasing laboratory capabilities.
As a result of the meeting, participants expressed their readiness for further development of inter-agency cooperation, strengthening international collaboration, and implementing new projects aimed at increasing the survival rates of children with oncological diseases and achieving strategic goals by 2030.
